Connect with us

Technology

NJ Labs ‘Going Beyond Testing’ Podcast Series Gives Honest Look at Testing Practices

Avatar

Published

on

NEW BRUNSWICK, N.J., Dec. 15, 2021 (GLOBE NEWSWIRE) — NJ Labs will release a new podcast series called, ‘Going Beyond Testing’ in 2022 to give companies and consumers an insider’s look at testing practices and what should be tested to keep products safe and effective. The series will cover the importance of analytical testing, emphasizing transparency and integrity in the testing practices and what’s required by testing labs to make dietary supplements, including cannabis and CBD products, as well as pharmaceutical drugs safe. The podcast series aims to educate both businesses and consumers about these practices, taking viewers through various areas of testing disciplines, including potency, heavy metal testing procedures, as well as highlighting what types of companies should be testing products.

The podcast content is delivered by Sandra Lee, CEO of NJ Labs, a privately owned FDA and DEA inspected facility that has been a mainstay in the testing industry for 85 years. Joining Lee as host and executive producer in the series is Mark Alyn, an award-winning journalist and executive director of “Late Night Health Radio,” a consumer-driven show focusing on a myriad of health topics in holistic naturopathic and traditional healthcare.

“Transparency is important in every aspect of our work with manufacturers and it is vital to the health and safety of consumers,” said Lee. “It’s important for companies to prove that a product is safe with testing, …

Full story available on Benzinga.com

Article: benzinga.com

Technology

Truist Sees 350% Upside on This Cancer-Focused Biopharma Stock – Read Why

Avatar

Published

on

Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside.
Analyst Srikripa Devarakonda notes that trading at about 2-times cash, the stock is “undervalued” given its programs in two cancers.
Devarakonda adds that the Verastem base case is supported by a $470 million unadjusted U.S. opportunity in the ovarian cancer program, “early but strong” clinical data, and positive expert feedback.
Related: 

Full story available on Benzinga.com

Article: benzinga.com

Continue Reading

Technology

“Peek Performance”: Apple’s Next Hardware Event Happens on March 8

Avatar

Published

on

Enlarge (credit: Apple)

Apple will stream its next hardware event to the masses on March 8 at 10 am Pacific (1 pm Eastern), the company announced today. Invitations have already been sent to the press—though the event will be yet another prerecorded, streaming-only presentation with no media in attendance. Apple marketing SVP Greg Joswiak tweeted the now-customary Apple-logo-centric teaser video that doesn’t actually tease anything.

We never know exactly what will be announced at any given Apple event, but Bloomberg’s Mark Gurman reports that the lineup will include a refresh of the budget-friendly iPhone SE and the first iPad Air update in a little over a year.

Rumors have also circulated about updated designs and new Apple Silicon chips for the MacBook Air and the 13-inch MacBook Pro, and the high-end Intel Mac Mini, the 27-inch iMac, and the Mac Pro are all still running Intel chips. The characteristically cryptic “peek performance” tagline does at least hint at new chips for one or more Macs, whether that’s a truly next-gen Apple M2 for thin-and-light laptops or an M1 Pro/Max-focused refresh for the more powerful desktops.

Read 1 remaining paragraphs | Comments

Original Article: arstechnica.com

Continue Reading

Technology

Charles River’s Q4 Earnings Beats Street Expectation, Reaffirms FY22 Outlook

Avatar

Published

on

Charles River Laboratories International Inc’s (NYSE: CRLQ4 sales increased 14.4% Y/Y to $905.1 million, beating the consensus of $888.27 million.

Acquisitions contributed 5.9% to consolidated fourth-quarter revenue growth. Organic revenue growth was 10.5%, driven by contributions from all three business segments. 
Adjusted EPS reached $2.49 higher than $2.39 posted a year ago and …

Full story available on Benzinga.com

Article: benzinga.com

Continue Reading

Trending

WOC.io